Sotera Health (NASDAQ:SHC) Sets New 1-Year Low – Here’s What Happened

Sotera Health (NASDAQ:SHC)’s share price reached a new 52-week low during trading on Thursday . The company traded as low as $10.71 and last traded at $10.73, with a volume of 609040 shares traded. The stock had previously closed at $11.50.

Wall Street Analysts Forecast Growth

SHC has been the topic of several analyst reports. Barclays decreased their price objective on Sotera Health from $17.00 to $16.00 and set an “overweight” rating on the stock in a report on Friday, February 28th. The Goldman Sachs Group began coverage on shares of Sotera Health in a research note on Friday, December 6th. They issued a “neutral” rating and a $14.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and an average price target of $16.00.

Sotera Health Stock Down 6.7 %

The company has a market capitalization of $3.04 billion, a price-to-earnings ratio of 42.92 and a beta of 1.92. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. The firm has a 50 day moving average price of $12.73 and a two-hundred day moving average price of $13.89.

Hedge Funds Weigh In On Sotera Health

Several large investors have recently modified their holdings of SHC. Blue Trust Inc. raised its stake in Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares during the period. Quarry LP acquired a new position in Sotera Health during the 4th quarter valued at about $28,000. GAMMA Investing LLC raised its holdings in Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after purchasing an additional 1,121 shares in the last quarter. Tower Research Capital LLC TRC boosted its stake in Sotera Health by 37.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock valued at $82,000 after buying an additional 1,640 shares in the last quarter. Finally, Sterling Capital Management LLC boosted its position in shares of Sotera Health by 58.5% during the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company’s stock valued at $124,000 after purchasing an additional 3,331 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.